Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious

Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious PR Newswire SINGAPORE, Aug. 13, 2012 - Increasing Investments and Focus on Medical Tourism Expected To Push Revenues to $3,063.2Million By 2016 SINGAPORE, Aug. 13, 2012 /PRNewswire/ -- The occurrence of infectious diseases – vector and blood borne – is high in Asia Pacific countries due to the tropical climate. While limited healthcare budgets had prevented most countries in the region from investing on diagnosis, treatment and elimination protocols, improving economies as well as funding and grants from international organizations have seen the adoption of earlier diagnosis and treatment strategies in recent years. New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), Asia Pacific Infectious Disease Diagnostics Market, expects the market to grow at 13.2 percent to reach revenues of $3,063.2 million by 2016. The study analyses the immunochemistry, molecular diagnostics and microbiology markets for the treatment of malaria, dengue, tuberculosis, HIV, hepatitis C, STI, influenza and pertussis. As Asian countries position themselves as a popular medical tourism destination, the need to control incidences of infectious disease is considered a priority. Hence these countries are focusing on ways to improve diagnosis of diseases in high risk endemic areas.